View Diseas page

Associated Therapies


Producer

Sunway Biotech Co. Ltd

Close

Therapy Approach

Last-stage refractory Nasopharyngeal cancer, NSCLC Lung cancer, Liver cancer,

Click For More

Last-stage refractory Nasopharyngeal cancer, NSCLC Lung cancer, Liver cancer, malignant pleural and peritoneal effusion and pancreatic cancer.

 

Case selection: patients are in advanced and refractory with relapse into cervical lymph node metastasis
Usage: local injection in cervical lymph node
Dosage: oncorine® is intratumoral injected at the dose of 1-3 vials per day, combined with 5-FU (500mg/m2) and cisplatin (20mg/m2). The schedule was continued for 5 days. The cycle was 21 days upto 2~5 cycles.

Lung cancer:

Case selection: Advanced non-small cell lung cancer, CT suggests that there has lesions suitable for injection.
Usage: Intratumoral injection through percutaneous lung puncture with needle guided with B ultrasound or CT
Dosage: Three vials of oncorine® at 1st and 8th day; start with chemotherapy in 4th day; The cycle is 21 days upto to 2~5 cycles.

Liver cancer:

Case selection: Primary or metastatic liver tumor with clinical or phathological diagnosis confirmed.
Usage & Dosage: During operation: regional perfusion or intratumoral injection of residual lesions with dose of 3 vials
Intervention procedure: Hepatic artery perfusion with dose of 3 vials. The cycle is 14 days up to 2~5 cycles.
Intrahepatic injection: Intratumoral injection through percutaneous and liver puncture guided with B ultrasound and the dose are 3 vials. The cycle is 14 days up to 2~5 cycles.

Malignant pleural and peritoneal effusions:

Case selection: Advanced tumor with malignant pleural and peritoneal effusions
Usage: Pleural and peritoneal perfusion
Dosage: Three vials of oncorine is used at1st and 4th day, and could be combined with local chemotherapy with pleural and peritoneal perfusion. The cycle is 14 days up to 2~5 cycles.

Pancreatic cancer:

Case selection: Incurable pancreatic cancer or recurrence after surgery
Usage: intratumoral injection is guide with EUS
Dosage: Three vials of oncorine combined with gemcitabine(1000mg/m2)Intravenous chemotherapy. The cycle is 28 days up to 2~5 cycles.

Availability


Patient Stories

Quality Approval


Details

Average Price

Therapy Name: Oncorine

Therapy Page

Producer

Eyetech Pharmaceuticals and Pfizer Inc

Close

Therapy Approach

Polynucleotide aptamer targeting vascular endothelial growth factor (VEGF)

Click For More

Polynucleotide aptamer targeting vascular endothelial growth factor (VEGF)

 

Availability


Patient Stories

Quality Approval

  • FDA Approved

Details

Average Price

Therapy Name: Macugen

Therapy Page

Producer

Shenzhen SiBiono GeneTech

Close

Therapy Approach

Head and neck squamous cell carcinoma (HNSCC)

Click For More

Head and neck squamous cell carcinoma (HNSCC)

Availability

  • United States

Patient Stories

Quality Approval

  • PMDA Approved

Details

Average Price

Therapy Name: Gendicine

Therapy Page

Producer

Ionis Pharmaceuticals

Close

Therapy Approach

Treatment of cytomegalovirus retinitis in HIV-patients

Click For More

Treatment of cytomegalovirus retinitis in HIV-patients

Availability

  • United States

Patient Stories

Quality Approval

  • FDA Approved

Details

Average Price

Therapy Name: Fomivirsen

Therapy Page

Producer

Kolon TissueGene

Close

Therapy Approach

Symptomatic and persistent knee osteoarthritis (OA)

Click For More

Symptomatic and persistent knee osteoarthritis (OA)

Availability

  • United States

Patient Stories

Quality Approval


Details

Average Price

Therapy Name: INVOSS

Therapy Page

Producer

Novartis Pharmaceuticals Corporation

Close

Therapy Approach

Patients up to 25 years of age with B-cell precursor ALL relapsed or refracto

Click For More

Patients up to 25 years of age with B-cell precursor ALL relapsed or refractory (r/r) large B-cell lymphoma

Availability

  • Switzerland
  • United States

Patient Stories

Quality Approval

  • FDA Approved

Details

Average Price

Therapy Name: Kymriah

Therapy Page

Producer

Dendreon Corporation

Close

Therapy Approach

Asymptomatic / minimally symptomatic metastatic castrate resistant (hormone r

Click For More

Asymptomatic / minimally symptomatic metastatic castrate resistant (hormone refractory) prostate cancer.

Availability

  • United States

Patient Stories

Quality Approval

  • FDA Approved

Details

Average Price

Therapy Name: Provenge

Therapy Page

Producer

Kite Pharma, Incorporated

Close

Therapy Approach

DLBCL, primary mediastinal large B-cell lymphoma, high-grade B-cell lymphoma

Click For More

DLBCL, primary mediastinal large B-cell lymphoma, high-grade B-cell lymphoma and DLBCL resulting from follicular lymphoma

Availability

  • United States

Patient Stories

Quality Approval

  • FDA Approved

Details

Average Price

Therapy Name: Yescarta

Therapy Page

Producer

Vericel Corporation

Close

Therapy Approach

Repair of single or multiple symptomatic, fullthickness cartilage defects of

Click For More

Repair of single or multiple symptomatic, fullthickness cartilage defects of the knee

Availability

  • United States

Patient Stories

Quality Approval

  • FDA Approved

Details

Average Price

Therapy Name: MACI

Therapy Page

Producer

Spark Therapeutics, Inc.

Close

Therapy Approach

Patients with confirmed biallelic RPE65 mutation-associated retinal dystrophy

Click For More

Patients with confirmed biallelic RPE65 mutation-associated retinal dystrophy

Availability

  • United States

Patient Stories

Quality Approval

  • FDA Approved

Details

Average Price

Therapy Name: LUXTURNA

Therapy Page

Producer

Fibrocell Technologies, Inc.

Close

Therapy Approach

Moderate to severe nasolabial fold wrinkles

Click For More

Moderate to severe nasolabial fold wrinkles

Availability

  • United States

Patient Stories

Quality Approval

  • FDA Approved

Details

Average Price

Therapy Name: Azficel-T

Therapy Page

Producer

SSM Cardinal Glennon Children's Medical Center

Close

Therapy Approach

unrelated donor HPC transplantation procedures in patients with disorders aff

Click For More

unrelated donor HPC transplantation procedures in patients with disorders affecting hematopoietic system

Availability

  • United States

Patient Stories

Quality Approval

  • FDA Approved

Details

Average Price

Therapy Name: ALLOCORD

Therapy Page